Evidence map›Paper›PMID 41716055›Full record

ArticleAnti-cancer agents in medicinal chemistry2026

Phytosynthesis of Selenium Nanoparticles from

Lorraine V Mary Rocha, R Lishanthi, S Madeena Begum, A Hadsun Jona, I Jaquline Chinna Rani

Abstract read
PubMed Publisher
In one paragraph

Article in Anti-cancer agents in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lorraine V Mary RochaDepartment of Plant Biology and Biotechnology & Loyola Institute of Frontier Energy (LIFE), Loyola College (Autonomous), University of Madras, Chennai, Tamil Nadu, India.ORCID 0000-0001-6083-3037
R LishanthiDepartment of Plant Biology and Biotechnology & Loyola Institute of Frontier Energy (LIFE), Loyola College (Autonomous), University of Madras, Chennai, Tamil Nadu, India.
S Madeena BegumDepartment of Plant Biology and Biotechnology & Loyola Institute of Frontier Energy (LIFE), Loyola College (Autonomous), University of Madras, Chennai, Tamil Nadu, India.
A Hadsun JonaDepartment of Plant Biology and Biotechnology & Loyola Institute of Frontier Energy (LIFE), Loyola College (Autonomous), University of Madras, Chennai, Tamil Nadu, India.
I Jaquline Chinna RaniDepartment of Plant Biology and Biotechnology & Loyola Institute of Frontier Energy (LIFE), Loyola College (Autonomous), University of Madras, Chennai, Tamil Nadu, India.ORCID 0000-0001-9523-5774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSelenium, a trace element with vital antioxidant and cancer-preventive properties, poses toxicity risks at higher doses, which can be mitigated through the green synthesis of nanoparticles using plant phytochemicals as natural reducing and stabilizing agents. This study aimed to investigate the potential of Morus rubra (L.) leaf extract as an effective natural reducing agent for the green synthesis of selenium nanoparticles, with an emphasis on their chemical characterization and assessment of biological activities.

methodsThe synthesized SeNPs were characterized using UV-Vis spectroscopy, FTIR, XRD, and TEM. Antimicrobial activity was evaluated using the agar well diffusion method, and MIC was determined by broth microdilution assay. Cytotoxic effects were assessed using the MTT assay, and apoptosis was evaluated using AO/EB dual staining.

resultsAn absorption peak at 275 nm confirmed successful SeNP biosynthesis, yielding 10-60 nm crystalline nanoparticles. The SeNPs exhibited potent antioxidant activity (IC DISCUSSION: These findings indicate that Morus rubra-mediated selenium nanoparticles align with recent advances in green nanotechnology, where plant extracts enhance both the safety and functional performance of nanoparticles.

conclusionThe biosynthesized selenium nanoparticles using Morus rubra leaf extract demonstrated efficient antioxidant, antimicrobial, and selective anticancer activities, highlighting their promising potential for biomedical applications.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsAntineoplastic Agents, PhytogenicAntioxidantsMorusNanoparticlesPlant ExtractsSeleniumApoptosisBacillus subtilisBiphenyl CompoundsCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorAnti-Bacterial AgentsAntifungal AgentsAntineoplastic AgentsAntineoplastic Agents, PhytogenicAntioxidantsBiphenyl CompoundsPicratesPlant ExtractsSeleniumantibacterial activityantioxidant activitybiocompatibilitycytotoxicitygreen synthesisMorus rubraSelenium nanoparticles

Identifiers

PMID41716055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.